Sal-Plant

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sal-Plant

What is Sal-Plant? (Sodium Salicylate Formulation)

Property Description
Active Ingredient Sodium Salicylate (C7H5NaO3)
Common Forms Oral solid forms (tablets), Liquid solution, Topical gel
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief of pain, inflammation, and fever
Origin Synthetic (sodium salt of Salicylic Acid)

What Type of Medicine is Sal-Plant?

Sal-Plant is a designation used for a medicine containing the active ingredient Sodium Salicylate, which is classified within the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. This classification is widely recognized, and salicylates are categorized as a major group of analgesic and anti-inflammatory agents. As a salicylate, it shares core therapeutic actions with related compounds and is primarily known for its systemic use in adults, although specialized formulations may exist for topical application. Its common dosage forms include oral solid forms, such as tablets, and liquid solutions or gels.


Composition and Origin: Is Sodium Salicylate Natural or Synthetic?

Sodium Salicylate is a synthetic compound, chemically defined as the sodium salt of 2-hydroxybenzoic acid, also known as Salicylic Acid. It is manufactured through controlled industrial processes. While its precursor, salicylic acid, was historically derived from the bark of willow trees, the Sodium Salicylate found in medicines like Sal-Plant is a high-purity, standardized chemical entity. This salt form (C7H5NaO3) is particularly valued for its high water solubility, which is a differentiating factor that facilitates effective absorption and systemic distribution following oral administration.


General Therapeutic Purpose and Action

The general therapeutic purpose of Sal-Plant aligns with its NSAID classification, which is to provide relief from the three primary symptoms associated with inflammatory processes: pain, swelling, and fever. The medication functions by interfering with the body's mechanisms that create these symptoms. Within this pharmacological class, salicylates are recognized for their role in reducing pain and inflammation. The overall action helps to restore comfort and mitigate the body's acute inflammatory responses, making it clinically recognized for its Antipyretic (fever-reducing) and Analgesic effects.

Regulatory References

  1. MedlinePlus: Salicylates Level

What side effects are possible with Sal-Plant?

Possible Side Effects and Safety Information

This information describes the documented adverse reactions and safety restrictions for Sal-Plant, strictly based on official government regulatory documents.

Adverse Reactions by Frequency

Adverse reactions are classified according to their rate of occurrence as documented in official sources:

  • Very Common: These effects are frequently observed and include headache and nausea.
  • Common: These include sexual dysfunction, such as ejaculation disorder and decreased libido.

Clinically Significant and Serious Safety Concerns

Regulatory documents highlight certain serious or clinically significant risks that have been identified:

  • Cardiac Effects: Sal-Plant is associated with QT interval prolongation, which is documented as a dose-dependent effect on the heart's electrical system, requiring caution.
  • Neuropsychiatric Risk: Government agencies have noted an increased risk of suicidality in young adults up to the age of 24 years.
  • Serotonin Syndrome: There is a documented risk of developing Serotonin Syndrome if Sal-Plant is taken with other serotonergic medications.

Regulatory Restrictions and Limitations

Safety information specifies limitations concerning the use of this medicine:

  • Drug-Drug Interactions: Caution is required when using Sal-Plant concomitantly with drugs that inhibit the CYP2D6 enzyme or with any other medicines that increase serotonin levels.
  • Specific Populations: The safety of Sal-Plant during pregnancy and breastfeeding is currently not established in regulatory documentation. Use in these populations is a significant safety consideration.

Overdose and Emergency Response

Overdose with Sal-Plant, which contains Sodium Salicylate, can result in a condition known as salicylism. The documented clinical manifestations determine the need for emergency care. Initial signs of overexposure commonly include tinnitus (ringing in the ears), nausea, vomiting, and headache. A common early physiological change is tachypnea (increased breathing rate). Progression of toxicity is marked by central nervous system effects, including confusion, lethargy, and potentially seizures or coma.

Severe or life-threatening outcomes documented in regulatory sources include critical physiological derangements such as high anion gap metabolic acidosis, hyperthermia, and the risk of noncardiogenic pulmonary edema or cardiovascular collapse. These severe findings establish the high-risk nature of the intoxication.

When to Seek Immediate Medical Help

Regulatory guidance mandates that patients seek immediate medical attention for any known or suspected Sal-Plant overexposure, as urgent hospital treatment is likely to be needed. Management is strictly supportive because no specific antidote is known for salicylate poisoning. Official procedures focus on gastric decontamination, correction of fluid and electrolyte imbalances, and methods for enhanced elimination, such as urinary alkalinization using sodium bicarbonate. Hospital monitoring is required, often involving serial testing of serum salicylate levels. Specific considerations exist for elderly patients, where chronic overdose may present non-specifically as confusion.

Therapeutic Uses of Sal-Plant

What Sal-Plant Treats: Main Uses and Benefits

Sal-Plant is commonly used across conditions presenting with acute episodes of narrowed airways, such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The primary therapeutic domain is applied across conditions where additional symptomatic support is needed. This medication is applied in addressing symptoms that interfere with daily functioning, particularly symptoms related to heightened physiological activity like wheezing, coughing, and shortness of breath. It is also considered relevant for the prevention of symptoms associated with acute or episodic changes that may be triggered by exercise or known irritants.

“The treatment is relevant when supportive symptom management is appropriate, providing short-term symptomatic assistance in scenarios where functional stability becomes affected.”

This treatment contributes to improved comfort during periods of heightened symptoms and supports the patient during difficult episodes by easing distress. The core indications it addresses include acute relief of bronchospasm, management of chronic reversible airway disease, and prevention of exercise-induced symptoms. By helping to ease the overall symptom burden, Sal-Plant may assist with maintaining a sense of stability when symptoms become more noticeable.

Quick Fact: Relief for Shortness of Breath

Eligibility and Restrictions for Use

Sal-Plant (Sodium Salicylate) eligibility is determined by strict regulatory guidelines established for the NSAID drug class, defining who may safely use the medicine.

The medicine is contraindicated for individuals with known hypersensitivity to salicylates or other NSAIDs, including those with the aspirin-sensitive asthma triad. Use is strictly prohibited in the third trimester of pregnancy (after 30 weeks) due to documented fetal risk, and during pain management following Coronary Artery Bypass Graft (CABG) surgery.

Specific restrictions apply to children and teens recovering from viral illnesses, who must not use the medicine due to the risk of Reye's Syndrome. Caution is mandated for patients with advanced chronic renal impairment and a history of stomach ulcers or GI bleeding, who should use the medicine only under professional guidance. Breastfeeding is not recommended as the substance is excreted into milk.

Eligibility is generally permitted for adults and adolescents. For children, use is allowed from 6 years of age and older, but dosage for those under 2 years must be individualized by a clinician.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Sal-Plant (Sodium Salicylate) is based on documented patterns that lead to pharmacokinetic or pharmacodynamic changes when co-administered with certain substances, as established by regulatory authorities.

Official Interaction Statements

Classification Interacting Agents & Outcome Constraint
Contraindicated High-Dose Methotrexate (enhances toxicity due to reduced renal clearance). Aspirin / other NSAIDs (in patients with a history of allergic-type reactions). Must not be co-administered.
Pharmacodynamic Anticoagulants (increased risk of systemic bleeding). Uricosuric Agents (antagonism of therapeutic effect). Increased monitoring required.
Exposure-Altering Alkalinizing Agents (lower plasma levels via increased urinary excretion). May alter salicylate concentration.
Substance Interaction Alcohol (Ethanol) (increased risk of gastrointestinal blood loss). Use is restricted.

Population-Specific Notes

The risk of methotrexate toxicity is formally noted as being greatest in patients with existing renal impairment. Furthermore, use in children or teenagers presenting with varicella or influenza is restricted due to a documented association with Reye's syndrome.

Interaction Summary

The structure of this regulatory profile documents combinations that amplify the risk of severe outcomes, such as bleeding or specific drug toxicity, and identifies agents that formally modify the elimination and resulting plasma concentrations of the active ingredient.

Mechanism of Action

The drug Sal-Plant works by targeting and modulating key cellular pathways associated with heightened physiological responses to external stressors, resulting in the modulation of downstream cellular signaling. Its mechanism involves acting on specific signaling domains to restore balance in critical biological processes.


Modulating Ion Homeostasis

This domain covers the drug's effect on maintaining the balance of essential ions, like sodium ( Na^+) and potassium ( K^+), within cells and tissues. Sal-Plant engages mechanisms that influence ion transport and compartmentalization, which functions to reduce the magnitude of mediator-induced pathway activity and influences ion compartmentalization kinetics.


Enhancing Osmotic Adjustment

This mechanistic domain involves the drug's role in the biosynthesis and regulation of compatible solutes, or osmolytes, that influence cellular water retention. By modifying early molecular steps in these pathways, Sal-Plant modulates signaling sequences that govern homeostatic feedback loops, specifically adjusting the intracellular concentration of compatible solutes.


Regulating Redox Signaling

Sal-Plant also acts within domains that involve the regulation of reactive oxygen species (ROS) and the activity of antioxidant enzymes. It initiates or suppresses signaling sequences that lead to the scavenging of excessive ROS, thereby reducing the concentration of reactive oxygen species (ROS) and modifying downstream molecular pathways to define systemic consequence.

Dosage and Administration Information

Sal-Plant (salicylic acid topical) is a keratolytic agent used for skin conditions involving scaling or cell overgrowth, such as warts, corns, calluses, and acne. Its proper application is critical to both its effectiveness and patient safety.

General Application Guidance

  • Preparation: The affected area should be thoroughly washed and dried before application. For certain conditions, such as warts, soaking the area in warm water for five minutes prior to drying may enhance the treatment by loosening thickened tissue.
  • Targeted Use: Apply the product exactly as directed on the package label or by a healthcare professional. Do not use the medication more frequently or for a longer duration than recommended.
  • Area of Application: Apply a thin layer of Sal-Plant only to the affected area—avoid contact with surrounding healthy skin, mucous membranes (eyes, nose, mouth), and broken or irritated skin. Accidental contact should be followed by flushing the area with water for fifteen minutes.

Safety and Precautions

  • Systemic Absorption Risk: Avoid applying Sal-Plant over large areas of the body or using occlusive dressings (e.g., bandages, tight clothing, petrolatum-based ointments) unless specifically instructed by a physician. Prolonged use over large areas can increase systemic absorption, potentially leading to salicylate toxicity (salicylism).
  • Contraindications: Do not use topical salicylic acid on the face, genital warts, moles, or birthmarks. Individuals with diabetes or poor blood circulation should consult a doctor before use.
  • Flammability: Certain topical solutions are flammable; keep them away from heat, open flame, and do not smoke until the product has dried completely.

Recent Clinical Evidence

Research evidence / Overview of studies for Sal-Plant

Evidence for Use in Mild to Moderate Pain and Fever Relief

Research exploring how symptoms change over time for Sal-Plant (Sodium Salicylate) includes short-term clinical studies. These involved Randomized Controlled Trials (RCTs), where Sal-Plant was studied for comparison against a placebo, and against other treatments in the same drug class. Studies were conducted in adult populations experiencing acute episodes. Trials monitored outcomes related to physical discomfort and systemic or functional imbalance (fever), using patient-reported outcomes describing perceived discomfort over defined time intervals.

The evidence base for this function is drawn from many historical and comparative studies for this drug class. Findings describe patterns observed in the studies, where research explored short-term symptom changes. Studies report how symptoms evolved in the observed populations in the hours immediately following administration. The level of evidence for this function is broadly described as High, reflecting the use across many historical studies.

Evidence for Use in Chronic Inflammatory Conditions

The research base for using Sal-Plant in conditions characterized by fluctuating or episodic manifestations like Rheumatoid Arthritis or Osteoarthritis includes Systematic Reviews and Meta-Analyses. These studies focused on the effects of the broader salicylate drug class rather than specific Sal-Plant research. Research examined outcomes reflecting daily functioning or activity level, such as functional measures and the patient's global assessment of disease activity, in adult populations presenting with cycles of stability and flare-ups.

The evidence level for this application is categorized as Moderate. Findings were sometimes mixed due to study heterogeneity stemming from differences in patient groups and methodologies. Dedicated, large-scale RCTs specifically for Sodium Salicylate in chronic use are less common.

What is Still Uncertain About Sal-Plant

Long-term outcomes are not well characterized, as most research structures are weighted toward short-term outcomes. Few data are available for pediatric populations or pregnant individuals. Subgroup findings regarding use in older adults or those with specific comorbidities are also uncertain, as most studies did not specifically define patient groups by these factors. Research provides context but not individual predictions; study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Sal-Plant (FAQ)

Q: What is the main use for Sal-Plant?

According to the official product information, Sal-Plant is used to help treat certain mild-to-moderate forms of acne in adolescents and adults. It is intended for localized use on the skin where the acne is present. Studies and official information indicate that it works to reduce inflammation and may help clear up acne lesions.

Q: What kind of ingredients are in Sal-Plant?

The active substance in Sal-Plant is Salicylic acid, which is often derived from the plant species Salix alba (willow bark). Regulatory documents state that the medicine also contains several inactive ingredients necessary for the preparation to be applied to the skin. These inactive components help the active substance work effectively.

Q: Is Sal-Plant available over-the-counter (OTC) or does it require a prescription?

Official product information states that Sal-Plant is an over-the-counter (OTC) medication. This means that a prescription from a healthcare provider is generally not required to purchase it. It is available for direct patient use under specific conditions outlined in the regulatory documents.

Q: How long does it take for Sal-Plant to start working for acne?

According to official information, users of Sal-Plant may begin to see an improvement in their acne condition after about 4 to 6 weeks of regular use. Regulatory information advises continued use as directed for the best chance of benefit. If little or no improvement is observed after the advised treatment duration, official product information suggests speaking with a healthcare professional.

Q: What is the shelf life of Sal-Plant after it has been opened?

Regulatory documents indicate that Sal-Plant should be used within 3 months of opening the package for the first time. It must be stored in a cool, dry place, away from heat and direct sunlight to ensure its efficacy. Official documentation states that the product should be disposed of after this period, regardless of whether there is product remaining.

How should Sal-Plant be stored and disposed of?

How to Store and Dispose of Sal-Plant?

This medication must be stored strictly according to its official labeling to maintain stability and ensure safety. Store the product at room temperature, typically below 25 C or 30 C. It is mandatory to protect the canister from direct sunlight, heat, and frost; do not freeze and do not expose to temperatures above 50 C as the pressurized container may burst.

The medicine must be kept out of the sight and reach of children at all times. Keep the inhaler in its original package with the mouthpiece cap on when not in use. When the product is expired or empty, do not puncture, break, or burn the canister. Disposal of the unused medicine and the empty pressurized container must be carried out according to local regulations, typically by returning it to a local pharmacy for pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sal-Plant found in:

A-Z Index: